Search for:
Author

Lim Ren Jun

Browsing
Ren Jun is an associate principal of Baker & McKenzie.Wong & Leow. Ren Jun extensively represents local and international intellectual property-intensive clients in both contentious and non-contentious IP matters, such as anti-counterfeiting; civil and criminal litigation; commercial issues; regulatory clearance; and advertising laws. Ren Jun also advises on a wide range of issues relating to the healthcare industries. These include regulatory compliance in respect of drugs, medical devices, clinical trials, health supplements and cosmetics; product liability and recall; and anti-corruption. Ren Jun is currently a member of the Firm's Asia Pacific Healthcare ASEAN Economic Community; Product Liability and Regulatory Sub-Committees.

On 26 February 2021, the Singapore Ministry of Health (MOH) announced that it is introducing a new voluntary listing of direct telemedicine service providers, to assist patients with making informed choices when selecting telemedicine service providers. According to the MOH, this scheme will be an interim measure to promote patient safety and welfare in the provision of telemedicine services, pending the upcoming regulation of telemedicine services under the new soon-to-be-implemented Healthcare Services Act.

On 26 February 2021, the Singapore Ministry of Health (MOH) announced that it is introducing a new voluntary listing of direct telemedicine service providers, to assist patients with making informed choices when selecting telemedicine service providers. According to the MOH, this scheme will be an interim measure to promote patient safety and welfare in the provision of telemedicine services, pending the upcoming regulation of telemedicine services under the new soon-to-be-implemented Healthcare Services Act.

On 26 February 2021, the Singapore Ministry of Health (MOH) announced that it is introducing a new voluntary listing of direct telemedicine service providers, to assist patients with making informed choices when selecting telemedicine service providers. According to the MOH, this scheme will be an interim measure to promote patient safety and welfare in the provision of telemedicine services, pending the upcoming regulation of telemedicine services under the new soon-to-be-implemented Healthcare Services Act.

Following the growing viability of meat substitutes such as plant-based meats and cultured meats, the Singapore Food Agency (SFA) has released an updated document detailing its requirements regarding the safety assessment of novel foods (“Safety Assessment Requirements”). This document is expected to be revised periodically as the novel food space evolves to facilitate industry safety assessments and maintain food safety standards.